In the last trading session, 1.23 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.41. Most recently the company’s share price was $0.70, and it changed around $0.04 or 6.38% from the last close, which brings the market valuation of the company to $205.57M. LYEL currently trades at a discount to its 52-week high of $3.26, offering almost -365.71% off that amount. The share price’s 52-week low was $0.51, which indicates that the current value has risen by an impressive 27.14% since then.
Lyell Immunopharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.50. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended LYEL as a Hold, whereas 0 deemed it a Buy, and 1 rated it as Underweight.
Lyell Immunopharma Inc (NASDAQ:LYEL) trade information
Instantly LYEL has showed a green trend with a performance of 6.38% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7326 on recent trading dayincreased the stock’s daily price by 4.45%. The company’s shares are currently up 9.94% year-to-date, but still up 7.00% over the last five days. On the other hand, Lyell Immunopharma Inc (NASDAQ:LYEL) is 19.19% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $1, which translates to bulls needing to increase their stock price by 30.0% from its current value. Analyst projections state that LYEL is forecast to be at a low of $1 and a high of $1.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -15.28%. Lyell Immunopharma Inc earnings are expected to increase by 23.30% in 2025, but the outlook is positive 17.62% per year for the next five years.
LYEL Dividends
Lyell Immunopharma Inc’s next quarterly earnings report is expected to be released in April.
ORLAND PROPERTIES LTD, with 5.91% or 15.09 million shares worth $21.89 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Price (T.Rowe) Health Sciences Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 5.82 shares worth $4.09 million, making up 1.99% of all outstanding shares. On the other hand, Price (T.Rowe) Health Sciences Fund held roughly 4.94 shares worth around $3.48 million, which represents about 1.69% of the total shares outstanding.
